XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Symbiosis Says It Recovered About 15 BTC After Bridge Exploit
Symbiosis said it recovered approximately 15 BTC and secured it in a team-controlled multisig, per CryptoSlate. The figure verifies the published attribution, n...
Senate to Hold First CLARITY Act Vote on Tuesday
The bill in focus is the Digital Asset Market Clarity Act, or CLARITY Act of 2025, which advanced through the House as H. R.
Schumer Calls Sunday Crypto Bill Caucus Ahead of Senate Vote
The account is unverified. A single source reported the caucus, and the underlying article was inaccessible, so no independent confirmation of who called the me...
Coinbase and Moov Plan Stablecoin Services for Local Banks
Coinbase describes Moov integrating its stablecoin infrastructure into Moov’s existing payments platform. The setup would use CDP Custodial Wallet accounts for...
BTCPay Warns Bots Probe Exposed LND Nodes for Admin Access
BTCPay Server has warned that automated bots are probing manually exposed LND nodes in an attempt to gain admin access, an activity the project says it observed...
Cosmos Hub Resumes Blocks; Ledger ATOM Issues Persist
Cosmos Hub has resumed block production after a multi-day disruption, but Ledger wallet issues persist for ATOM balances and transfers as of September 13, 2026....
